Article
Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
Journal of inherited metabolic disease - 1 Oct 2010
Sommerburg Olaf, Lindner Martin, Muckenthaler Martina, Kohlmueller Dirk, Leible Svenja, Feneberg Reinhard, Kulozik Andreas E, Mall Marcus A, Hoffmann Georg F
Abstract excerpt
BACKGROUND: Ethical concerns and disadvantages of newborn screening (NBS) for cystic fibrosis (CF) related to genetic testing have raised controversies and impeded implementation of CF NBS in some countries. In the present study, we used a prospective and sequential immunoreactive trypsinogene (I...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
